| Literature DB >> 31744153 |
Carmen X Luzuriaga-Quichimbo1, José Blanco-Salas2, Luz María Muñoz-Centeno3, Rafael Peláez4, Carlos E Cerón-Martínez5, Trinidad Ruiz-Téllez2.
Abstract
We carried out surveys on the use of Cordia nodosa Lam. in the jungles of Bobonaza (Ecuador). We documented this knowledge to prevent its loss under the Framework of the Convention on Biological Diversity and the Nagoya Protocol. We conducted bibliographic research and identified quercetrin as a significant bioactive molecule. We studied its in silico biological activity. The selected methodology was virtual docking experiments with the proteins responsible for the venomous action of snakes. The molecular structures of quercetrin and 21 selected toxins underwent corresponding tests with SwissDock and Chimera software. The results point to support its antiophidic use. They show reasonable geometries and a binding free energy of -7 to -10.03 kcal/mol. The most favorable values were obtained for the venom of the Asian snake Naja atra (5Z2G, -10.03 kcal/mol). Good results were also obtained from the venom of the Latin American Bothrops pirajai (3CYL, -9.71 kcal/mol) and that of Ecuadorian Bothrops asper snakes (5TFV, -9.47 kcal/mol) and Bothrops atrox (5TS5, -9.49 kcal/mol). In the 5Z2G and 5TS5 L-amino acid oxidases, quercetrin binds in a pocket adjacent to the FAD cofactor, while in the myotoxic homologues of PLA2, 3CYL and 5TFV, it joins in the hydrophobic channel formed when oligomerizing, in the first one similar to α-tocopherol. This study presents a case demonstration of the potential of bioinformatic tools in the validation process of ethnobotanical phytopharmaceuticals and how in silico methods are becoming increasingly useful for sustainable drug discovery.Entities:
Keywords: Cordia; antiophidic; docking; in silico; quercetrin; validation
Mesh:
Substances:
Year: 2019 PMID: 31744153 PMCID: PMC6891429 DOI: 10.3390/molecules24224160
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Rosmarinic acid.
Figure 2Quercetrin.
Medicinal uses given to the species retrieved from our fieldwork prospections and literature review.
| Organ/System | Part Used | Formulation | Traditional Knowledge | Ethnic Group-Province (Country) | Reference |
|---|---|---|---|---|---|
| Circulatory system | leaves | decoction | hypertension | Amerindian NorthWest District (Guiana) | [ |
| Digestive system | gases | Siona-Sucumbíos (Ecuador) | [ | ||
| Respiratory system | bark | cooking | treat cough | Secoya-Sucumbíos (Ecuador) | [ |
| stem | |||||
| inner bark | finely grate and decoction | cold and shortness of breath | Amerindian (French Guiana) | [ | |
| leaves | decoction | whooping cough | Amerindian NorthWest District (Guiana) | [ | |
| fruit | suck | snot in babies | Amerindian NorthWest District (Guiana) | [ | |
| Musculature and skeleton | leaves | crush the leaves and rub the body with them | rheumatism, sprains, muscle aches, bruises | Amerindian NorthWest District (Guiana) | [ |
| Nervous system and mental illness | leaves | baths with the decoction of the leaves | madness and psychiatric disorders | Yanesha (Perú) | [ |
| decoction | headache | Amerindian NorthWest District (Guiana) | [ | ||
| Symptoms and states of undefined origin | bark | indeterminate conditions | Secoya-Sucumbíos (Ecuador) | [ | |
| flowers | Kichwa del Oriente-Orellana (Ecuador) | ||||
| fruit | energizing | Wao-Orellana (Ecuador) | |||
| leaves | infusion | dizziness | ethnicity not specified-Napo (Ecuador) | ||
| decoction | fever | Amerindian NorthWest District (Guiana) | [ | ||
| Poisoning | leaves | apply directly in the affected place | spider bite, to decrease inflammation and prevent gangrene | East Kichwa-Napo and Orellana (Ecuador) | [ |
| fruit | |||||
| plant | cooking | ||||
| bark | cooking | ||||
| root | cooking | ||||
| bark | scraped and in water | snake bites, to decrease inflammation and prevent gangrene | East Kichwa, Shuar-Napo, Orellana, Pastaza, Sucumbíos (Ecuador), Piaroa (Venezuela) | [ | |
| infusion | |||||
| root | infusion | ||||
| stem | juice | ||||
| fruit | juice | ||||
| young leaves | chewed | ||||
| leaves | apply directly in the affected place |
Toxins from Ecuadorian (1–2), Latin American (3–13) or non-American (14–21) snakes, and the corresponding Protein Data Base Identifier (PDB ID).
| Toxin | PDB ID | Reference |
|---|---|---|
| 1. MT-I—Basic phospholipase a2 myotoxin iii | 5TFV | [ |
| 2. LAAO—L-amino acid oxidase from | 5TS5 | [ |
| 3. PLA2—Phospholipase A2: Piratoxin I (myotoxic Lys49-PLA2) from | 3CYL | [ |
| 4. PLA2—Phospholipase A2: BthTX-I—Bothropstoxin I from | 3CXI | [ |
| 5. PLA2—Phospholipase A2: Myotoxin (MjTX-I) from | 6CE2 | [ |
| 6. PLA2—Phospholipase A2: Bothropstoxin I (BthTX-I) | 6DIK | [ |
| 7. svPLA2—Phospholipase A2: myotoxin II from | 1XXS | [ |
| 8. LAAO—L-amino acid oxidasefrom the | 4E0V | [ |
| 9. svPLA2—Acidic phospholipase A2 (BthA-I) from | 1Z76 | [ |
| 10. VRV-PL-V—Crotoxin B, the basic PLA2 from | 2QOG | [ |
| 11. PLA2—Piratoxin-II (Prtx-II) - a K49 PLA2 from | 1QLL | [ |
| 12. Bothropasin, the Main Hemorrhagic Factor from | 3DSL | [ |
| 13. SVMP—P-I snake venom metalloproteinase BaP1 | 2W12 | [ |
| 14. NNH1—L-amino acid oxidase from venom of | 5Z2G | [ |
| 15. LAAO—L-amino acid oxidase from | 3KVE | [ |
| 16. PDE I—Phosphodiesterase (PDE) from Taiwan cobra ( | 5GZ4 | [ |
| 17. VRV-PL-V—Phospholipase ACII4 from Australian King Brown Snake ( | 3V9M | [ |
| 18. NN-PL-I—Phospholipase A2 from indian cobra ( | 1PSH | [ |
| 19. LAAO—L-amino acid oxidase from Agkistrodon Halys Pallas ( | 1REO | [ |
| 20. NNH1—Phosphodiesterase (PDE) fromTaiwan cobra ( | 5GZ5 | [ |
| 21. PLA2—Phospholipase A2 (Pla2) from | 1A3D | [ |
The liaison energies of quercetrin with the PDB ID studied targets.
| 1. 5TFV | −9.71 | MT-I—Basic Phospholipase a2 Myotoxin iii |
| 2. 5TS5 | −9.47 | LAAO—L-amino acid oxidase from |
| 3. 3CYL | −9.49 | PLA2—Phospholipase A2: Piratoxin I (myotoxic Lys49-PLA2) from |
| 4. 3CXI | −9.37 | PLA2—Phospholipase A2: BthTX-I—Bothropstoxin I from |
| 5. 4GUE | −9.30 | N-terminal kinase domain of RSK2 with flavonoid glycoside quercetrin |
| 6. 6CE2 | −9.19 | PLA2—Phospholipase A2: Myotoxin (MjTX-I) from |
| 7. 6DIK | −9.16 | PLA2—Phospholipase A2: Bothropstoxin I (BthTX-I) |
| 8. 1XXS | −9.01 | svPLA2—Phospholipase A2: myotoxin II from |
| 9. 4E0V | −8.96 | LAAO—L-amino acid oxidasefrom the |
| 10. 1Z76 | −8.56 | svPLA2—Acidic phospholipase A2 (BthA-I) from |
| 11. 2QOG | −8.32 | VRV-PL-V—Crotoxin B, the basic PLA2 from |
| 12. 5A4W | −8.28 | AtGSTF2 from |
| 13. 1QLL | −8.23 | PLA2—Piratoxin-II (Prtx-II) - a K49 PLA2 from |
| 14. 3DSL | −8.20 | Bothropasin, the Main Hemorrhagic Factor from |
| 15. 2W12 | −7.71 | SVMP—P-I snake venom metalloproteinase BaP1 |
Figure 35TFV-quercetrin complex. in the most favourable arrangement (a) and augmented (b) showing the disposition between the chain of toxins. Right: 2D interaction diagram.
Figure 45TS5-quercetrin complex. in the most favourable arrangement (a) and augmented (b) showing the disposition between the chain of toxins. Right: 2D interaction diagram.
Figure 53CYL quercetrin complex in the most favourable arrangement (a) and augmented (b) showing the disposition between the chain of toxins. Right: 2D interaction diagram.
Figure 63CXI-quercetrin complex in the most favourable arrangement (a) and augmented (b) showing the disposition between the chain of toxins. Right: 2D interaction diagram.
Figure 76CE2-q uercetrin complex in the most favourable arrangement (a) and augmented (b) showing the disposition between the chain of toxins. Right: 2D interaction diagram.
Figure 86DIK-quercetrin complex in the most favourable arrangement (a) and augmented (b) showing the disposition between the chain of toxins. Right: 2D interaction diagram.
Figure 91XXS-quercetrin complex in the most favourable arrangement (a) and augmented (b) showing the disposition between the chain of toxins. Right: 2D interaction diagram.
Figure 104E0V-quercetrin complex in the most favourable arrangement (a) and augmented (b) showing the disposition between the chain of toxins. Right: 2D interaction diagram.
Figure 111Z76-quercetrin complex in the most favourable arrangement (a) and augmented (b) showing the disposition between the chain of toxins. Right: 2D interaction diagram.
Figure 122QOG-quercetrin complex in the most favourable arrangement (a) and augmented (b) showing the disposition between the chain of toxins. Right: 2D interaction diagram.
Figure 131QLL-quercetrin complex in the most favourable arrangement (a) and augmented (b) showing the disposition between the chain of toxins. Right: 2D interaction diagram.
Figure 143DSL-quercetrin complex in the most favourable arrangement (a) and augmented (b) showing the disposition between the chain of toxins. Right: 2D interaction diagram.
Figure 152W12-quercetrin complex in the most favourable arrangement (a) and augmented (b) showing the disposition between the chain of toxins. Right: 2D interaction diagram.
Similarity matrix for the target proteins. In each cell the upper number represents the percentage of identity and the lower the percentage of similarity for the protein in that row. The number in parenthesis represent the corresponding amino-acid number after Smith-Waterman comparison of the sequences. The cells are colored according to the percentage of similarity: <25% yellow, 25–50% orange, 50-75% green and >75% light blue. Diagonal cells with 100% identity are colored in dark blue. The protein IDs in the upper row have been colored by groups according to their similarity to the rest of the sequences.
| 4GUE | 5A4W | 1QLL | 1XXS | 1Z76 | 2QOG | 2W12 | 3CXI | 3CYL | 3DSL | 4E0V | 5TFV | 5TS5 | 6CE2 | 6DIK | |
| 4GUE | 100% | 2.95% (9) | 1.64% (5) | 1.64 % (5) | 1.97 % (6) | 1.31% (4) | 8.20% (25) | 1.97% (6) | 1.64% (5) | 5.90% (18) | 8.52% (26) | 1.97% (6) | 6.23% (19) | 1.31 % (4) | 1.97 % (6) |
| 5A4W | 4.25% (9) | 100 | 2.36% (5) | 2.83% (6) | 2.83% (6) | 3.77% (8) | 6.60% (14) | 2.36% (5) | 2.62% (13) | 4.25% (9) | 19.81% (42) | 2.36% (5) | 19.81% (42) | 5.19% (11) | 2.36% (5) |
| 1QLL | 4.13% (5) | 4.13 % (5) | 100% | 93.39% (113) | 48.76% (59) | 48.76% (59) | 4.96% (6) | 98.35% (119) | 99.17% (120) | 14.05% (17) | 19.83 % (24) | 60.33% (73) | 5.79 % (7) | 86.78% (105) | 99.17% (120) |
| 1XXS | 4.10% (5) 7.38% | 4.92% (6) | 92.62% | 100% | 50.82% (62) | 49.18% (60) | 4.92% (6) | 94.26% (115) | 92.62% (113) | 13.93% (17) | 9.84% (12) | 59.84% (73) | 4.10% (5) | 82.79% (101) | 93.44% (114) |
| 1Z76 | 4.92% (6) | 4.92% (6) | 48.36% (59) | 50.82% (62) | 100% | 56.56% (69) | 7.38% (9) | 50.0 % (61) | 48.36% (59) | 18.85% (23) | 8.20% (19) | 56.56% (69) | 8.20% (10) | 50.00% (61) | 49.18% (60) |
| 2QOG | 3.28% (4) | 6.56% (8) | 48.36% | 49.18% (60) | 56.56% (69) | 100% | 7.38% (9) | 47.54% (58) | 48.36% (59) | 22.13% (27) | 9.84% (12) | 63.93% (78) | 9.84% (12) | 47.54% (58) | 48.36% (59) |
| 2W12 | 12.38% (25) | 6.93% (14) | 2.97 % (6) | 2.97% (6) | 4.46% (9) | 4.46% (9) | 100% | 2.97% (6) | 2.97% (6) | 52.48% (106) | 3.47% (7) | 1.98% (4) | 3.47% (7) | 7.92% (16) | 2.97% (6) |
| 3CXI | 4.96% (6) | 4.13% (5) | 98.35% (119) | 95.04% (115) | 50.41% (61) | 47.93% (58) | 4.96% (6) | 100% | 98.35% (119) | 14.05% (17) | 19.83% (24) | 59.50% (72) | 5.79% (7) | 85.95% (104) | 99.17% (120) |
| 3CYL | 4.13% (5) | 10.74% (13) | 99.17% (120) | 93.39% (113) | 48.76% (59) | 48.76% (59) | 4.96% (6) | 98.35% (119) | 100% | 14.05% (17) | 19.83% (24) | 59.50% (72) | 5.79% (7) | 87.60% (106) | 99.17% (120) |
| 3DSL | 4.30% (18) | 2.15% (9) | 4.06% (17) | 4.06% (26) | 5.49% (23) | 6.44% (35) | 25.30% (106) | 4.06% (17) | 4.06% (17) | 100% | 2.39% (10) | 4.06% (17) | 2.39% (10) | 4.06% (17) | 4.06% (17) |
| 4E0V | 5.23% (26) | 8.45% (42) | 4.83% (24) | 2.41% (12) | 2.01% (19) | 2.41% (12) | 1.41% (7) | 4.83% (24) | 4.83% (24) | 2.01% (10) | 100% | 3.22% (16) | 95.37% (474) | 2.41% (12) | 4.83% (24) |
| 5TVF | 4.92% (6) | 4.10% (5) | 59.84% (73) | 59.84% (73) | 56.56% (69) | 63.93% (78) | 3.28% (4) | 59.02% (72) | 59.02% (72) | 13.93% (17) | 13.11% (16) | 100% | 13.11% (16) | 56.56% (69) | 59.02% (72) |
| 5TS5 | 3.93% (19) | 8.68% (42) | 1.45 % (7) | 1.03% (5) | 2.07% (10) | 2.48% (12) | 1.45% (7) | 1.45% (7) | 1.45% (7) | 2.07% (10) | 97.93% (474) | 3.31% (16) | 100% | 2.48% (12) | 1.45% (7) |
| 6CE2 | 3.31% (4) | 9.09% (11) | 86.78% (105) | 83.47% (101) | 50.41% (61) | 47.93% (58) | 13.22% (16) | 85.95% (104) | 87.60% (106) | 14.05% (17) | 9.92% (12) | 57.02% (69) | 9.92% (12) | 100% | 86.78% (105) |
| 6DIK | 4.96 % (6) | 4.13% (5) | 99.17% (120) | 94.21% (114) | 49.59% (60) | 48.76% (59) | 4.96% (6) | 99.17% (120) | 99.17% (120) | 14.05% (17) | 19.83% (43) | 59.50% (72) | 5.79% (7) | 86.78% (105) | 100% |